Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial-Reference-Cited by-同舟云学术

Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial

Published:2016-08 Issue:8 Volume:17 Page:1070-1080
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Piperno-Neumann Sophie,Le Deley Marie-Cécile,Rédini Françoise,Pacquement Hélène,Marec-Bérard Perrine,Petit Philippe,Brisse Hervé,Lervat Cyril,Gentet Jean-Claude,Entz-Werlé Natacha,Italiano Antoine,Corradini Nadège,Bompas Emmanuelle,Penel Nicolas,Tabone Marie-Dominique,Gomez-Brouchet Anne,Guinebretière Jean-Marc,Mascard Eric,Gouin François,Chevance Aurélie,Bonnet Naïma,Blay Jean-Yves,Brugières Laurence

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Osteosarcoma: current treatment and a collaborative pathway to success;Isakoff;J Clin Oncol,2015

2. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

3. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols;Bielack;J Clin Oncol,2002

4. Pleiotropic effects of bisphosphonates on osteosarcoma;Ohba;Bone,2014

5. American society of clinical oncology clinical practice guideline update: recommendations on the role of bone-modifying agents in metastatic breast cancer;Van Poznak;J Oncol Pract,2011

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint-regulatable hydrogel-immobilized nanotherapeutics for post-surgical treatment of osteosarcoma;Chemical Engineering Journal;2024-10

2. Metallocompounds as anticancer agents against osteosarcoma;Drug Discovery Today;2024-09

3. Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO;European Journal of Cancer;2024-09

4. Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials;European Journal of Cancer;2024-09

5. Intratumoral Heterogeneity Assessment of the Extracellular Bone Matrix and Immune Microenvironment in Osteosarcoma Using Digital Imaging to Predict Therapeutic Response;Laboratory Investigation;2024-09